Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

460
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

768
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

619
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
619
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

817
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
817

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultra-high-pressure generation in the relativistic transparency regime in laser-irradiated nanowire arrays.

Physical review. E·2023
Same author

Luminous, relativistic, directional electron bunches from an intense laser driven grating plasma.

Scientific reports·2022
Same author

A European consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients.

Anaesthesia·2020
Same author

Enhancement of laser-focused intensity greater than 10 times through a re-entrant cone in the petawatt regime.

Optics letters·2020
Same author

Direct observation of imploded core heating via fast electrons with super-penetration scheme.

Nature communications·2019
Same author

The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the Haemostasis and Transfusion Scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology.

Anaesthesia·2019

Related Experiment Video

Updated: May 4, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K

Perioperative factor concentrate therapy.

K A Tanaka1, S Esper, D Bolliger

  • 1Department of Anaesthesiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

British Journal of Anaesthesia
|December 17, 2013
PubMed
Summary
This summary is machine-generated.

Allogeneic plasma transfusion is life-saving but slow. Factor concentrates offer rapid, targeted haemostasis for trauma and surgical bleeding, overcoming plasma

Keywords:
antithrombin concentratecoagulation monitoringcryoprecipitatefibrinogen concentratefresh-frozen plasmaprothrombin complex concentrate

More Related Videos

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

615
Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
09:31

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

2.3K

Related Experiment Videos

Last Updated: May 4, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

615
Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
09:31

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism

Published on: February 14, 2022

2.3K

Area of Science:

  • Transfusion Medicine
  • Haemostasis and Thrombosis
  • Perioperative Care

Background:

  • Allogeneic plasma transfusion is a critical intervention for severe trauma and surgical blood loss.
  • While pathogen transmission risks have decreased, plasma transfusion is limited by thawing time and infusion volume.
  • Plasma-derived and recombinant factor concentrates are available for targeted replacement of coagulation factors.

Purpose of the Study:

  • To review the rationale for utilizing factor concentrates in perioperative haemostatic management.
  • To discuss the limitations of plasma transfusion in managing perioperative bleeding.
  • To highlight the benefits of factor concentrates in rapidly restoring deficient coagulation factors.

Main Methods:

  • Review of existing literature on plasma transfusion and factor concentrate therapy.
  • Analysis of clinical indications for factor concentrates in hereditary bleeding disorders.
  • Discussion of the application of factor concentrates in perioperative settings.

Main Results:

  • Factor concentrate therapy allows rapid restoration of deficient factors without volume overload.
  • Perioperative haemostatic defects are often multifactorial, requiring careful clinical judgment and testing.
  • Factor concentrates offer a faster and more targeted approach compared to plasma transfusion.

Conclusions:

  • Factor concentrates represent a valuable tool in perioperative haemostatic management.
  • Appropriate use of factor concentrates, guided by clinical judgment and coagulation testing, is essential.
  • Factor concentrates provide an effective alternative to plasma transfusion, addressing its inherent limitations.